Oncoinvent A

Oncoinvent A Dividend Coverage

Dividend Coverage Ratio of Oncoinvent A (ONCIN.OL) as of Nov 7, 2026.

Dividend Coverage

-

Last updated:

Dividend Coverage Ratio of Oncoinvent A is 2026 - . Dividend Coverage Ratio of Oncoinvent A was 2025 - . It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Oncoinvent A Stock analysis

What does Oncoinvent A do? Oncoinvent ASA is a radiopharmaceutical company based in Oslo, Norway, operating within the Health Care sector. Listed on 13 December 2024, the firm employs 46 people and focuses on developing alpha-emitting radiotherapeutics for cancer patients. Its primary product, Radspherin, is an alpha-emitting radioactive microsphere therapy designed to treat metastatic cancers in body cavities. This suspension of calcium carbonate microspheres labelled with Radium-224 targets residual micro-metastases on intracavitary surfaces and in liquids after surgery, aiming to spare deeper organs from harmful radiation doses. Oncoinvent A is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Oncoinvent A stock

On Eulerpool you can find the complete historical development of Dividend Coverage Ratio Oncoinvent A since 2006 – with annual values, charts, and detailed analysis.

The dividend coverage ratio measures how many times dividends can be covered by net income. Higher coverage suggests more sustainable dividend payments.

Dividend Coverage Ratio's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Dividend Coverage Ratio's Oncoinvent A historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Dividend — Oncoinvent A

All Key Metrics — Oncoinvent A